Keywords: Myocardium, Cardiomyopathy
Motivation: CMR, the gold standard for diagnosing myocardial diseases, is known for its ability to assess local myocardial fibrosis through LGE imaging. However, this imaging technique requires a contrast agent, limiting its use in patients with allergies or renal dysfunction.
Goal(s): The purpose of this study is to assess the ability of MVs/MVd as a new indicator to measure the extent of myocardial fibrosis.
Approach: Explore the correlation between MVs/MVd and LGE% in patients with hypertrophic cardiomyopathy.
Results: The results indicate that MVs/MVd may possess the ability to indicate myocardial fibrosis without the need for a contrast agent.
Impact: MVs/MVd, in contrast to traditional methods, directly measures the entire cardiac cycle, offering valuable insights into myocardial properties. Importantly, it can gauge myocardial fibrosis to some extent without requiring a contrast agent, making it clinically significant for diagnosis and treatment.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords